GatesFoundationWRFCapitalAcademic&ResearchInstitutionsNon-DilutiveFundingSyndicationPartnersHarvardMedicalSchoolLydianNeurosciencesLewisCantleyUniformedServicesUniversityStrategicPartnershipsRodeoTherapeuticsVentureCapital$12.3MillionNIDAGrantTachiYamada,M.D.Neuroscience& NeurologySundarKodiyalamDanaFarberCancerCapital-efficiencyExceptionalTrackRecordLeroyHood,M.D.,Ph.D.MDAndersonCancerCenterCSABMembers?ApogenBiotechnologiesARCHVenturePartnersSeattleOfficeEmployeesReviewed >4,000OpportunitiesUTSouthwestern$3.375BillionExitSanDiegoOfficeCPRITJanLundberg,Ph.D.Top-tierInvestorsLodoTherapeuticshigh-quality,cutting edgelife sciencecompaniesEliLillyOperatingPartners?Divestitures(BARDA)– onupdatedslide deckSingaporeOfficeUniversityofMinnesotaColumbiaUniversityPronirasWeillCornellMedicinePetraPharmaGeneYeo,Ph.D.$1 BillionGenentechCollaborationTheRockefellerUniversityPennStateTheRockefellerUniversity150+Years’ExperienceAlexandriaVentureInvestmentsMagnoliaNeurosciencesLodoTherapeuticsDiversity58.43%IRRWeillCornellMedicineSyndicationNewYorkOfficeTemasekScientists&TechnologyDevelopers2.85DVPIInfectiousDisease,Oncology,MicrobiomeTurn-KeyFacilitiesTargetedTherapeutic(Asset)FinancingAdvisory&CorporateBoardsScientificExpertiseSteveGillis,Ph.D.Oncology1.02DPICaseWesternReserveUTSouthwesternMedicalCenterPfizerVenturesAI &MachineLearningFund Inet IRRof 58.4%Entrepreneurs2014 Top-quartileRankedAbbvieCorporateSpinoutsRodeoTherapeuticsSubstantialExitHistoryWuXiPharmaTechGatesFoundationBruceL.A.Carter,Ph.D.GatesFoundationWRFCapitalAcademic&ResearchInstitutionsNon-DilutiveFundingSyndicationPartnersHarvardMedicalSchoolLydianNeurosciencesLewisCantleyUniformedServicesUniversityStrategicPartnershipsRodeoTherapeuticsVentureCapital$12.3MillionNIDAGrantTachiYamada,M.D.Neuroscience& NeurologySundarKodiyalamDanaFarberCancerCapital-efficiencyExceptionalTrackRecordLeroyHood,M.D.,Ph.D.MDAndersonCancerCenterCSABMembers?ApogenBiotechnologiesARCHVenturePartnersSeattleOfficeEmployeesReviewed >4,000OpportunitiesUTSouthwestern$3.375BillionExitSanDiegoOfficeCPRITJanLundberg,Ph.D.Top-tierInvestorsLodoTherapeuticshigh-quality,cutting edgelife sciencecompaniesEliLillyOperatingPartners?Divestitures(BARDA)– onupdatedslide deckSingaporeOfficeUniversityofMinnesotaColumbiaUniversityPronirasWeillCornellMedicinePetraPharmaGeneYeo,Ph.D.$1 BillionGenentechCollaborationTheRockefellerUniversityPennStateTheRockefellerUniversity150+Years’ExperienceAlexandriaVentureInvestmentsMagnoliaNeurosciencesLodoTherapeuticsDiversity58.43%IRRWeillCornellMedicineSyndicationNewYorkOfficeTemasekScientists&TechnologyDevelopers2.85DVPIInfectiousDisease,Oncology,MicrobiomeTurn-KeyFacilitiesTargetedTherapeutic(Asset)FinancingAdvisory&CorporateBoardsScientificExpertiseSteveGillis,Ph.D.Oncology1.02DPICaseWesternReserveUTSouthwesternMedicalCenterPfizerVenturesAI &MachineLearningFund Inet IRRof 58.4%Entrepreneurs2014 Top-quartileRankedAbbvieCorporateSpinoutsRodeoTherapeuticsSubstantialExitHistoryWuXiPharmaTechGatesFoundationBruceL.A.Carter,Ph.D.

Home for the Holidays (& everyday) - Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
  1. Gates Foundation
  2. WRF Capital
  3. Academic & Research Institutions
  4. Non-Dilutive Funding
  5. Syndication Partners
  6. Harvard Medical School
  7. Lydian Neurosciences
  8. Lewis Cantley
  9. Uniformed Services University
  10. Strategic Partnerships
  11. Rodeo Therapeutics
  12. Venture Capital
  13. $12.3 Million NIDA Grant
  14. Tachi Yamada, M.D.
  15. Neuroscience & Neurology
  16. Sundar Kodiyalam
  17. Dana Farber Cancer
  18. Capital-efficiency
  19. Exceptional Track Record
  20. Leroy Hood, M.D., Ph.D.
  21. MD Anderson Cancer Center
  22. CSAB Members?
  23. Apogen Biotechnologies
  24. ARCH Venture Partners
  25. Seattle Office
  26. Employees
  27. Reviewed > 4,000 Opportunities
  28. UT Southwestern
  29. $3.375 Billion Exit
  30. San Diego Office
  31. CPRIT
  32. Jan Lundberg, Ph.D.
  33. Top-tier Investors
  34. Lodo Therapeutics
  35. high-quality, cutting edge life science companies
  36. Eli Lilly
  37. Operating Partners?
  38. Divestitures
  39. (BARDA) – on updated slide deck
  40. Singapore Office
  41. University of Minnesota
  42. Columbia University
  43. Proniras
  44. Weill Cornell Medicine
  45. Petra Pharma
  46. Gene Yeo, Ph.D.
  47. $1 Billion Genentech Collaboration
  48. The Rockefeller University
  49. Penn State
  50. The Rockefeller University
  51. 150+ Years’ Experience
  52. Alexandria Venture Investments
  53. Magnolia Neurosciences
  54. Lodo Therapeutics
  55. Diversity
  56. 58.43% IRR
  57. Weill Cornell Medicine
  58. Syndication
  59. New York Office
  60. Temasek
  61. Scientists & Technology Developers
  62. 2.85 DVPI
  63. Infectious Disease, Oncology, Microbiome
  64. Turn-Key Facilities
  65. Targeted Therapeutic (Asset) Financing
  66. Advisory & Corporate Boards
  67. Scientific Expertise
  68. Steve Gillis, Ph.D.
  69. Oncology
  70. 1.02 DPI
  71. Case Western Reserve
  72. UT Southwestern Medical Center
  73. Pfizer Ventures
  74. AI & Machine Learning
  75. Fund I net IRR of 58.4%
  76. Entrepreneurs
  77. 2014 Top-quartile Ranked
  78. Abbvie
  79. Corporate Spinouts
  80. Rodeo Therapeutics
  81. Substantial Exit History
  82. WuXi PharmaTech
  83. Gates Foundation
  84. Bruce L.A. Carter, Ph.D.